JPMORGAN CHASE & CO - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$36,372,000
+1319.1%
1,058,899
+590.1%
0.01%
Q2 2020$2,563,000
+72.1%
153,433
+48.5%
0.00%
Q1 2020$1,489,000
-62.5%
103,289
-13.0%
0.00%
-100.0%
Q4 2019$3,972,000
+47.3%
118,700
-7.8%
0.00%0.0%
Q3 2019$2,696,000
+11.0%
128,715
+5.6%
0.00%
Q2 2019$2,429,000
-15.5%
121,928
-5.2%
0.00%
-100.0%
Q1 2019$2,876,000
-17.4%
128,634
-11.6%
0.00%0.0%
Q4 2018$3,482,000
-12.6%
145,586
-0.3%
0.00%0.0%
Q3 2018$3,982,000
+8.4%
145,966
+6.8%
0.00%0.0%
Q2 2018$3,675,000
-19.1%
136,677
-4.3%
0.00%0.0%
Q1 2018$4,544,000
-25.7%
142,751
-11.7%
0.00%0.0%
Q4 2017$6,112,000
-15.6%
161,609
-45.1%
0.00%
-50.0%
Q3 2017$7,240,000
+2.7%
294,405
-14.1%
0.00%0.0%
Q2 2017$7,047,000
+23.0%
342,757
+30.1%
0.00%
+100.0%
Q1 2017$5,727,000
-5.4%
263,532
-11.0%
0.00%0.0%
Q4 2016$6,057,000
+121.1%
296,187
+62.2%
0.00%0.0%
Q3 2016$2,740,000
+138.9%
182,650
+72.4%
0.00%
Q2 2016$1,147,000
+99.8%
105,975
+150.5%
0.00%
Q1 2016$574,00042,3000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders